Cargando…
Countering the problem of falsified and substandard drugs /
"The adulteration and fraudulent manufacture of medicines is an old problem, vastly aggravated by modern manufacturing and trade. In the last decade, impotent antimicrobial drugs have compromised the treatment of many deadly diseases in poor countries. More recently, negligent production at a M...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor Corporativo: | |
| Otros Autores: | , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Washington, D.C. :
National Academies Press,
[2013]
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | EBSCO_ocn839275199 | ||
| 003 | OCoLC | ||
| 005 | 20231017213018.0 | ||
| 006 | m o d | ||
| 007 | cr ||||||||||| | ||
| 008 | 130408t20132013dcuab obt 000 0 eng d | ||
| 040 | |a COO |b eng |e rda |e pn |c COO |d GPM |d MMU |d AKU |d OCLCO |d OCLCA |d UCNAP |d CUS |d OCLCF |d OCLCO |d CUS |d VT2 |d E7B |d N$T |d YDXCP |d OCLCO |d OCLCQ |d OCLCO |d EBLCP |d OCLCO |d AGLDB |d MERUC |d OCLCQ |d ZCU |d OCLCA |d OCLCO |d OCLCA |d U3W |d OCLCA |d BUF |d OCLCO |d GILDS |d STF |d VNS |d OCLCO |d OCLCQ |d VTS |d EZ9 |d OCLCA |d ICG |d OCLCO |d CUY |d OCLCO |d REC |d OCLCO |d AU@ |d OCLCO |d OCLCQ |d WYU |d OCLCA |d LVT |d OCLCA |d S9I |d TKN |d DKC |d OCLCO |d OCLCQ |d OCLCO |d M8D |d OCLCO |d OCLCQ |d K6U |d OCLCA |d VLY |d OCLCO |d CUV |d VHC |d OCLCO |d OCLCQ |d OCL |d OCLCO | ||
| 019 | |a 880439886 |a 880598095 |a 929505330 |a 932320631 |a 961541600 |a 962566672 |a 1013281256 |a 1021249589 |a 1028757444 |a 1048158507 |a 1055345724 |a 1066010422 |a 1081203238 |a 1142730752 |a 1156364339 |a 1162554800 |a 1176019756 |a 1225734707 |a 1228558864 |a 1229699560 |a 1241869177 |a 1249222552 |a 1290089510 |a 1300664907 |a 1303326026 |a 1303518494 | ||
| 020 | |a 9780309269407 | ||
| 020 | |a 0309269407 | ||
| 020 | |z 9780309269391 |q (paperback) | ||
| 020 | |z 0309269393 |q (paperback) | ||
| 029 | 1 | |a DEBBG |b BV042793458 | |
| 029 | 1 | |a DEBBG |b BV043027550 | |
| 029 | 1 | |a DEBBG |b BV043624924 | |
| 029 | 1 | |a DEBBG |b BV044184838 | |
| 029 | 1 | |a DEBSZ |b 446432784 | |
| 035 | |a (OCoLC)839275199 |z (OCoLC)880439886 |z (OCoLC)880598095 |z (OCoLC)929505330 |z (OCoLC)932320631 |z (OCoLC)961541600 |z (OCoLC)962566672 |z (OCoLC)1013281256 |z (OCoLC)1021249589 |z (OCoLC)1028757444 |z (OCoLC)1048158507 |z (OCoLC)1055345724 |z (OCoLC)1066010422 |z (OCoLC)1081203238 |z (OCoLC)1142730752 |z (OCoLC)1156364339 |z (OCoLC)1162554800 |z (OCoLC)1176019756 |z (OCoLC)1225734707 |z (OCoLC)1228558864 |z (OCoLC)1229699560 |z (OCoLC)1241869177 |z (OCoLC)1249222552 |z (OCoLC)1290089510 |z (OCoLC)1300664907 |z (OCoLC)1303326026 |z (OCoLC)1303518494 | ||
| 050 | 4 | |a HD9665.5 |b .I578 2013 | |
| 060 | 4 | |a QV 773 | |
| 072 | 7 | |a BUS |x 070000 |2 bisacsh | |
| 082 | 0 | 4 | |a 338.4/76151 |2 23 |
| 049 | |a UAMI | ||
| 110 | 2 | |a Institute of Medicine (U.S.). |b Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products, |e author. | |
| 245 | 1 | 0 | |a Countering the problem of falsified and substandard drugs / |c Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products, Board on Global Health ; Gillian J. Buckley and Lawrence O. Gostin, editors ; Institute of Medicine of the National Academies. |
| 264 | 1 | |a Washington, D.C. : |b National Academies Press, |c [2013] | |
| 264 | 4 | |c ©2013 | |
| 300 | |a 1 online resource (xxiv, 351 pages) : |b illustrations (chiefly color), color maps | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 347 | |a data file |2 rda | ||
| 520 | |a "The adulteration and fraudulent manufacture of medicines is an old problem, vastly aggravated by modern manufacturing and trade. In the last decade, impotent antimicrobial drugs have compromised the treatment of many deadly diseases in poor countries. More recently, negligent production at a Massachusetts compounding pharmacy sickened hundreds of Americans. While the national drugs regulatory authority (hereafter, the regulatory authority) is responsible for the safety of a country's drug supply, no single country can entirely guarantee this today. The once common use of the term counterfeit to describe any drug that is not what it claims to be is at the heart of the argument. In a narrow, legal sense a counterfeit drug is one that infringes on a registered trademark. The lay meaning is much broader, including any drug made with intentional deceit. Some generic drug companies and civil society groups object to calling bad medicines counterfeit, seeing it as the deliberate conflation of public health and intellectual property concerns. Countering the Problem of Falsified and Substandard Drugs accepts the narrow meaning of counterfeit, and, because the nuances of trademark infringement must be dealt with by courts, case by case, the report does not discuss the problem of counterfeit medicines"--Publisher's description. | ||
| 504 | |a Includes bibliographical references. | ||
| 505 | 0 | |a Introduction -- The effects of falsified and substandard drugs -- The magnitude of the problem -- Causes of falsified and substandard drugs -- Weaknesses in the drug distribution chain -- Detection technology -- An international code of practice for falsified and substandard medicines. | |
| 546 | |a English. | ||
| 536 | |a Supported by the National Academy of Sciences and the U.S. Food and Drug Administration |b HHSF22301024T |g 25 | ||
| 588 | 0 | |a Online resource; title from resource home page (National Academies Press, viewed June 12, 2013). | |
| 590 | |a eBooks on EBSCOhost |b EBSCO eBook Subscription Academic Collection - Worldwide | ||
| 650 | 0 | |a Pharmaceutical industry. | |
| 650 | 0 | |a Pharmaceutical industry |x Quality control. | |
| 650 | 0 | |a Fraud |x Prevention. | |
| 650 | 0 | |a Quality control. | |
| 650 | 0 | |a International cooperation. | |
| 650 | 1 | 2 | |a Counterfeit Drugs |
| 650 | 1 | 2 | |a Fraud |x prevention & control |
| 650 | 2 | 2 | |a Drug Contamination |x prevention & control |
| 650 | 2 | 2 | |a Pharmaceutical Preparations |x standards |
| 650 | 2 | 2 | |a Quality Control |
| 650 | 2 | 2 | |a International Cooperation |
| 650 | 2 | |a Drug Industry | |
| 650 | 6 | |a Industrie pharmaceutique |x Qualité |x Contrôle. | |
| 650 | 6 | |a Industrie pharmaceutique. | |
| 650 | 6 | |a Qualité |x Contrôle. | |
| 650 | 6 | |a Coopération internationale. | |
| 650 | 7 | |a quality control. |2 aat | |
| 650 | 7 | |a BUSINESS & ECONOMICS |x Industries |x General. |2 bisacsh | |
| 650 | 7 | |a Quality control |2 fast | |
| 650 | 7 | |a International cooperation |2 fast | |
| 650 | 7 | |a Fraud |x Prevention |2 fast | |
| 650 | 7 | |a Pharmaceutical industry |2 fast | |
| 650 | 7 | |a Pharmaceutical industry |x Quality control |2 fast | |
| 700 | 1 | |a Buckley, Gillian J., |e editor. | |
| 700 | 1 | |a Gostin, Lawrence O. |q (Lawrence Ogalthorpe), |e editor. | |
| 776 | 0 | 8 | |i Online version: |a Institute of Medicine (U.S.). Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products. |t Countering the problem of falsified and substandard drugs. |d Washington, D.C. : National Academies Press, 2013 |z 9780309269391 |w (OCoLC)850372447 |
| 856 | 4 | 0 | |u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=867887 |z Texto completo |
| 938 | |a ProQuest Ebook Central |b EBLB |n EBL3564286 | ||
| 938 | |a ebrary |b EBRY |n ebr10863743 | ||
| 938 | |a EBSCOhost |b EBSC |n 867887 | ||
| 938 | |a YBP Library Services |b YANK |n 11864774 | ||
| 994 | |a 92 |b IZTAP | ||